Physician profile
Mark W Roark
NPI 1598890907
$5,911.18
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,225 · 2020: $805 · 2021: $2,707 · 2022: $1,157 · 2023: $16.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Entertainment: $16.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Entertainment | $16.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,508.46 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $1,137.50 | 2021 | |
| Mallinckrodt Hospital Products INC. | $538.21 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $417.60 | 2019 | |
| Sun Pharmaceutical Industries INC. | $414.92 | 2019-2022 | |
| Shire North American Group INC | $298.75 | 2019 | |
| Allergan, INC. | $279.34 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $189.78 | 2019-2022 | |
| Coopervision INC. | $177.64 | 2019-2021 | |
| Oyster Point Pharma, INC. | $149.46 | 2022 | |
| Bausch & Lomb Americas INC. | $144.92 | 2022 | |
| Lombart Brothers, INC. | $131.72 | 2019 | |
| Maculogix, INC. | $99.13 | 2019 | |
| Tearlab Corp | $82.61 | 2022 | |
| Quidel Corporation | $79.67 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $78.43 | 2022 | |
| Kala Pharmaceuticals, INC. | $60.26 | 2020-2021 | |
| Optos, INC. | $39.03 | 2022-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $25.47 | 2022 | |
| Sight Sciences, INC. | $23.10 | 2021 | |
| Biotissue Holdings INC. | $18.83 | 2019 | |
| Abbvie INC. | $16.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Roark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.